C4 Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in C4 Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $15M | 2.6M | 5.65 |
2023-09-30 | $4.1M | 2.2M | 1.86 |
2023-06-30 | $7.8M | 2.8M | 2.75 |
2023-03-31 | $9.0M | 2.9M | 3.14 |
2022-12-31 | $17M | 2.9M | 5.90 |
2022-03-31 | $106M | 4.4M | 24.26 |
2021-12-31 | $132M | 4.1M | 32.20 |
2021-09-30 | $177M | 4.0M | 44.68 |
2021-06-30 | $134M | 3.5M | 37.84 |
2021-03-31 | $78M | 2.1M | 36.99 |
2020-12-31 | $49M | 1.5M | 32.27 |